Healthcare runs on information that too often sits in silos, which is why Jason Rose, chief executive officer of Clearsense, set out to turn data into a usable asset that supports quality, cost control and discovery.
Rose stepped into a founder-led organization and focused the company on problems health systems face every day. He tightened alignment across product, delivery and customer success so outcomes in the field shaped what came next. Culture was strengthened without losing the entrepreneurial spark that launched the platform.
The mission is straightforward. Clearsense helps health systems revitalize data, retire wasteful systems, improve decision cycles, support research and drive better care. Rose built pathways that move from ingestion to action with reliability so leaders know what to decommission, what to preserve and how to activate intelligence across the enterprise.
Application lifecycle management became a defining pillar. Under Rose, the company positioned itself to help organizations archive responsibly, unwind technical debt and protect information while freeing resources for modern needs. That capability sits beside analytics and research enablement so knowledge from the past informs today’s breakthroughs in discovery and care delivery.
Market response validated the strategy. Rose guided a brand evolution, advanced platform direction and deepened partnerships with systems known for size and complexity. Engagements expanded to include portfolio management solutions and archived data services that reduce risk while keeping information useful. A high-visibility client win and an analyst case study in progress reflect momentum earned through execution rather than hype.
Industry peers regard Rose as a decisive operator who invites candid feedback and closes loops quickly. He protects speed with guardrails that serve customers and treats every deployment as a chance to refine playbooks for the next one. As a Titan 100 Honoree, he is recognized for blending vision with results across a sector where reliability matters as much as innovation.
A five-year picture guides the next chapter. Rose envisions a landscape where retiring obsolete applications becomes standard practice, archived data is easy to search and insights travel from dashboards to the point of care. Responsible use of artificial intelligence will augment workflows without adding noise. Clearsense will continue unifying data, lifecycle management and research support so organizations can act faster with confidence.
Pride centers on progress that helps caregivers focus, scientists move quicker and finance teams find relief from tangled portfolios. Rose measures value in the language of the client and removes friction that blocks adoption. The charge remains simple and demanding: build tools that respect the realities of a hospital day, deliver service that earns trust and prove that better information changes outcomes.
Through steady stewardship grounded in purpose, Rose shows preeminence and influence in data-driven healthcare while shaping a company designed to make insight practical at scale.
